공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 반려동물용 의약품 시장 조사 보고서 : 적응별, 동물 종류별, 유통 채널별 - 예측(-2025년) - COVID-19의 누적 영향

Companion Animal Pharmaceuticals Market Research Report by Indication, by Animal Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 1005004
페이지 정보 영문 180 Pages
가격
US $ 3,949 ₩ 4,523,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,669,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,105,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,396,000 PDF (Enterprise License) + Excel


세계의 반려동물용 의약품 시장 조사 보고서 : 적응별, 동물 종류별, 유통 채널별 - 예측(-2025년) - COVID-19의 누적 영향 Companion Animal Pharmaceuticals Market Research Report by Indication, by Animal Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 180 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 반려동물용 의약품 시장 규모는 2020년 112억 6,548만 달러에서 2025년 말까지 170억 6,782만 달러로 확대될 것으로 예측됩니다.

COVID-19는 미증유의 세계적인 공중위생상 긴급사태이며, 모든 업계에 영향을 미쳐 왔습니다. 이 장기적 영향은 예측기간 중 업계의 성장에 영향을 미칠 것으로 예측됩니다. 우리가 진행하고 있는 조사에서는 기저에 있는 COVID-19의 문제와 향후 방향을 확실히 다루기 위해 조사 범위를 확대시키고 있습니다. 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재라우팅, 현재 시장 동향 및 정부의 중요한 개입 등을 고려하면서, COVID-19에 대한 인사이트를 제공합니다. 업데이트된 조사에서는 COVID-19가 시장에 미치는 영향을 고려하고, 인사이트, 분석, 예측 등을 제공합니다.

세계의 반려동물용 의약품(Companion Animal Pharmaceuticals) 시장에 대해 조사했으며, 시장 개요와 함께 적응별, 동물 종류별, 유통 채널별, 지역별 동향, COVID-19의 누적 영향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상 연도
  • 통화와 가격
  • 언어
  • 제한
  • 이해관계자

제2장 조사 방법

  • 조사 과정
    • 정의 : 조사 목적
    • 결정 : 조사 디자인
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 갱신
  • 조사 실행
    • 개시 : 조사 과정
    • 계획 : 조사 계획 작성
    • 실행 : 조사 실시
    • 검증 : 발견과 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 주요 요약

  • 서론
  • 시장 전망
  • 적응별 전망
  • 유통 채널별 전망
  • 동물 종류별 전망
  • 지역별 전망
  • 경쟁사별 전망

제4장 시장 개요

  • 서론
  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porter's Five Forces 분석
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 고객의 협상력
    • 공급 기업의 협상력
    • 업계의 경쟁

제6장 세계의 반려동물용 의약품 시장, 적응별

  • 행동장애
  • 피부질환
  • 감염증
  • 정형외과 질환
  • 통증

제7장 세계의 반려동물용 의약품 시장, 동물 종류별

  • 고양이

제8장 세계의 반려동물용 의약품 시장, 유통 채널별

  • 소매 약국
  • 수의 클리닉
  • 동물 병원

제9장 아메리카의 반려동물용 의약품 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제10장 아시아태평양의 반려동물용 의약품 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제11장 유럽, 중동 및 아프리카의 반려동물용 의약품 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제12장 경쟁 상황

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 계약, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금 조달
    • 상, 표창, 확대

제13장 기업 유저빌리티 개요

  • Ashish Life Science Pvt. Ltd.
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals plc
  • Eco Animal Health Group plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hipra
  • Indian Immunologicals Ltd.
  • Inovet
  • Kyoritsu Seiyaku
  • Lutim Pharma Pvt. Ltd.
  • Merck & Co. Inc.
  • Norbrook Holdings Limited
  • Tianjin Ringpu Bio-Technology Co. Ltd.
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc.
  • Zydus Animal Health and Investments Limited

제14장 부록

  • 논의 가이드
  • 라이선스와 가격
KSM 21.05.21

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2026
  • FIGURE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 18. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (%)
  • FIGURE 22. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2026
  • FIGURE 24. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
  • FIGURE 31. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
  • FIGURE 33. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 40. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 42. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. CALIFORNIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. FLORIDA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. ILLINOIS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. NEW YORK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. OHIO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. PENNSYLVANIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. TEXAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 55. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 57. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 66. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 68. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 80. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 81. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. CALIFORNIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. CALIFORNIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. CALIFORNIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. FLORIDA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. FLORIDA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. FLORIDA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. ILLINOIS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. ILLINOIS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. ILLINOIS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. NEW YORK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. NEW YORK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. NEW YORK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. OHIO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. OHIO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. OHIO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. PENNSYLVANIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. PENNSYLVANIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. PENNSYLVANIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. TEXAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. TEXAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. TEXAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SCORES
  • TABLE 124. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BUSINESS STRATEGY
  • TABLE 125. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: PRODUCT SATISFACTION
  • TABLE 126. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: RANKING
  • TABLE 127. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 128. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 129. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: MERGER & ACQUISITION
  • TABLE 130. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 131. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 132. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: INVESTMENT & FUNDING
  • TABLE 133. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 134. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: LICENSE & PRICING
  • TABLE 135. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: CONTACT DETAILS

The Global Companion Animal Pharmaceuticals Market size was estimated at USD 11.26 Billion in 2020 and expected to reach USD 12.29 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 9.50% to reach USD 19.42 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Companion Animal Pharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Indication, the Companion Animal Pharmaceuticals Market was studied across Behavioral Disorders, Dermatologic Diseases, Infectious Diseases, Orthopedic Diseases, and Pain.

Based on Animal Type, the Companion Animal Pharmaceuticals Market was studied across Cats, Dogs, and Horses.

Based on Distribution Channel, the Companion Animal Pharmaceuticals Market was studied across Retail Pharmacies, Veterinary Clinics, and Veterinary Hospitals.

Based on Geography, the Companion Animal Pharmaceuticals Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Companion Animal Pharmaceuticals Market, including Ashish Life Science Pvt. Ltd., Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals plc, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Endovac Animal Health, Hipra, Indian Immunologicals Ltd., Inovet, Kyoritsu Seiyaku, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Holdings Limited, Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac, Zoetis Inc., and Zydus Animal Health and Investments Limited.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Companion Animal Pharmaceuticals Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Companion Animal Pharmaceuticals Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Companion Animal Pharmaceuticals Market?
  • 4. What is the competitive strategic window for opportunities in the Global Companion Animal Pharmaceuticals Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Companion Animal Pharmaceuticals Market?
  • 6. What is the market share of the leading vendors in the Global Companion Animal Pharmaceuticals Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Companion Animal Pharmaceuticals Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Indication Outlook
  • 3.4. Distribution Channel Outlook
  • 3.5. Animal Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of zoonotic diseases
      • 5.1.1.2. Rising availability and adoption of pet health insurance
      • 5.1.1.3. Rising initiatives by government and private organisation to promote animal health
    • 5.1.2. Restraints
      • 5.1.2.1. High storage cost for vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising development of new drugs
      • 5.1.3.2. Growing investment by key players
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with the approval for drugs
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Companion Animal Pharmaceuticals Market, by Indication

  • 6.1. Introduction
  • 6.2. Behavioral Disorders
  • 6.3. Dermatologic Diseases
  • 6.4. Infectious Diseases
  • 6.5. Orthopedic Diseases
  • 6.6. Pain

7. Companion Animal Pharmaceuticals Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Cats
  • 7.3. Dogs
  • 7.4. Horses

8. Companion Animal Pharmaceuticals Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Retail Pharmacies
  • 8.3. Veterinary Clinics
  • 8.4. Veterinary Hospitals

9. Americas Companion Animal Pharmaceuticals Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Companion Animal Pharmaceuticals Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Companion Animal Pharmaceuticals Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Ashish Life Science Pvt. Ltd.
  • 13.2. Boehringer Ingelheim GmbH
  • 13.3. Ceva Sante Animale
  • 13.4. Chanelle Pharma
  • 13.5. Dechra Pharmaceuticals plc
  • 13.6. Eco Animal Health Group plc
  • 13.7. Elanco Animal Health Incorporated
  • 13.8. Endovac Animal Health
  • 13.9. Hipra
  • 13.10. Indian Immunologicals Ltd.
  • 13.11. Inovet
  • 13.12. Kyoritsu Seiyaku
  • 13.13. Lutim Pharma Pvt. Ltd.
  • 13.14. Merck & Co. Inc.
  • 13.15. Norbrook Holdings Limited
  • 13.16. Tianjin Ringpu Bio-Technology Co. Ltd.
  • 13.17. Vetoquinol S.A.
  • 13.18. Virbac
  • 13.19. Zoetis Inc.
  • 13.20. Zydus Animal Health and Investments Limited

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details
Back to Top
전화 문의
F A Q